Lecture 19 Flashcards
thrombus
in vivo (inside)
clot
in vitro (outside)
Arterial thrombus
platelets plus WBC in fibrin mesh (white)
Venous thrombus
Fibrin, platelets, RBC (red)
Mechanism of hemostasis (2)
collagen exposed-platelets stick and activate
ADP and 5-HT(powerful vasoconstrictor) released
Platelet activation and adhesion
platelet activation arrows (6)
Platelets aggregate and adhere via fibrinogen binding between GP2b/3a receptors->soft plug formed
PLA2->arachadonic acid-COX->TXA2->Ca->adhesion and aggregation
Stimuli for platelet activation (4)
collagen
thrombin
thomboxane (TXA2)
ADP
What does thrombin cleave
fibrinogen->fibrin
Activation of prothrombin(cascade rxn)(2)
extrinsic-in vivo-damages tissues release thromboplastin
Intrinsic-in vitro-exposed collagen or other material, negative charges
Coagulation cascade(3)
amplification
factors are proteases
Extrinsic pathway faster
Control of blood coagulation by (2)
(2) including steps
enzyme inhibitors (eg. Antithrombin 3->cascade inhibition) fibrinolysis by plasmin: thrombin+thrombomodulin->activates protein C->inactivation of 5,8, inhibitor of tissue plasminogen->plasminogen->plasmin->fibrinolysis
Situations of blood stasis leading to thrombus formation
Atrial fibrillation: cerebral, renal, saddle thrombosis
Deep Vein Thrombosis (DVT);pulmonary embolism
Situations of blood vessel damage leading to thrombus formation
2 locations and what they cause
Atherosclerosis (plaque build up)
- coronary-myocardial infarction
- carotid artery-stroke
Drugs affecting fibrin formation(3 and ex)
procoag drugs- Vit K
injectable anticoagulants eg Heparin
oral anticoagulants- warfarin
Injectable coagulants: Heparin
action
why is it injectable
enhances activity of antithrombin 3->inactivates factor 10 and thrombin
it is largely negatively charged so not orally available
What does Activated partial thromboplastin time (aPTT) measure
intrinsic pathway
used to monitor effect of heparin
Warfarin and its derivatives
what is its action?
where is it active
how long does it take to work
Inhibit reduction of vit K (2,7,9,10)->inhibiting gamma glutamyl carboxylase
only active in vivo(inside)-orally available
delayed onset of action because it does not affect already active factors (could take days to see effects)
Adverse effects of warfarin
and reversal
hemorrhage
reversal with vit K (oral) and fresh frozen plasma
Monitoring the effect of coumarin and rodenticide poisoning
prothrombin time (PT) extrinsic pathway
What other drugs will affect warfarin activity
aspirin- impaired platelet activity
NSAIDs- competition form plasma protein binding
Alcohol- Competition from cytochrome p450 pathway so dec warfarin clearance->inc availability
TXA2 synthesis
and what is thromboxane
thromboxane is a potent platelet activator
synthesized in platelets from arachadonic acid
Rxn catalysed by COX
Aspirin is leads to(3)
irreversible COX inhibitor
dec TXA2 synthesis
dec platelet aggregation
Low dose aspirin therapy-why does it work(3)
platelets exposed to aspirin in portal vein->bind COX->dec platelet aggregation
90% aspirin cleared in first pass metabolism
beneficial vasodilation is preserved (kidneys)